Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission

BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been established for the treatment of acute myeloid leukemia patients for over 30 years with a cure rate of 50% to 60%. OBJECTIVES: To analyze the overall survival of patients and identify factors that influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bueno, Nadjanara Dorna, Dulley, Frederico Luiz, Saboya, Rosaura, Amigo Filho, José Ulysses, Coracin, Fabio Luiz, Chamone, Dalton de Alencar Fischer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415735/
https://www.ncbi.nlm.nih.gov/pubmed/23049292
http://dx.doi.org/10.5581/1516-8484.20110050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415735/
https://www.ncbi.nlm.nih.gov/pubmed/23049292
http://dx.doi.org/10.5581/1516-8484.20110050

Ejemplares similares